Patents by Inventor James J. L'Italien

James J. L'Italien has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20150080308
    Abstract: Provided herein are formulations containing exendins, exendin agonists and/or exendin analogs and methods of using the exendins, exendin agonists and/or exendin analogs and formulations thereof to treat glucagonoma and necrolytic migratory erythema, or to suppress glucagon secretion.
    Type: Application
    Filed: November 25, 2014
    Publication date: March 19, 2015
    Inventors: Orville G. KOLTERMAN, Andrew A. YOUNG, James J. L'ITALIEN
  • Publication number: 20110281798
    Abstract: Novel formulations containing exendins, exendin agonists and/or exendin analogs are provided.
    Type: Application
    Filed: March 10, 2011
    Publication date: November 17, 2011
    Applicant: AMYLIN PHARMACEUTICALS, INC.
    Inventors: Orville G. KOLTERMAN, Andrew A. Young, James J. L'Italien
  • Patent number: 7906146
    Abstract: Novel formulations containing exendins, exendin agonists and/or exendin analogs are provided.
    Type: Grant
    Filed: February 20, 2009
    Date of Patent: March 15, 2011
    Assignee: Amylin Pharmaceuticals, Inc.
    Inventors: Orville G. Kolterman, Andrew A. Young, James J. L'Italien
  • Publication number: 20090215694
    Abstract: Novel formulations containing exendins, exendin agonists and/or exendin analogs are provided.
    Type: Application
    Filed: February 20, 2009
    Publication date: August 27, 2009
    Applicant: AMYLIN PHARMACEUTICALS, INC
    Inventors: Orville G. Kolterman, Andrew A. Young, James J. L'Italien
  • Publication number: 20080249018
    Abstract: Novel formulations containing exendins, exendin agonists and/or exendin analogs are provided
    Type: Application
    Filed: April 10, 2008
    Publication date: October 9, 2008
    Applicant: Amylin Pharmaceuticals, Inc.
    Inventors: Orville G. KOLTERMAN, Andrew A. YOUNG, James J. L'ITALIEN
  • Patent number: 7399489
    Abstract: Novel formulations containing exendins, exendin agonists and/or exendin analogs are provided.
    Type: Grant
    Filed: November 10, 2005
    Date of Patent: July 15, 2008
    Assignee: Amylin Pharmaceuticals, Inc.
    Inventors: Orville G. Kolterman, Andrew A. Young, James J. L'Italien
  • Patent number: 4548904
    Abstract: A protein sequencing method utilizing a composition of matter which comprises a D-C-B-A reagent wherein A is a moiety which can react with and bind to a terminal amino acid of a protein and can result in removal of the terminal amino amino acid, B is a moiety which provides steric separation between C and A, C is a nucleophilic moiety which can be detected, and D is a moiety which protects the C moiety from degradation or other modification, and is labile in acidic media and stable in neutral or basic media. The protein sequencing method and reagent can be used in micro sequencing apparatus.
    Type: Grant
    Filed: December 3, 1982
    Date of Patent: October 22, 1985
    Assignee: Molecular Genetics Research & Development
    Inventors: Stephen B. H. Kent, James J. L'Italien